MEDTRN — Meditrina Cyprus Cashflow Statement
0.000.00%
- €4.50m
- €4.49m
- €6.47m
- 55
- 96
- 31
- 68
Annual cashflow statement for Meditrina Cyprus, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final |
Net Income/Starting Line | 0.473 | -0.157 | 0.736 | 0.721 |
Depreciation | ||||
Amortisation | ||||
Non-Cash Items | -0.036 | -0.146 | -0.621 | -0.284 |
Unusual Items | ||||
Equity in Net Earnings/Losses | ||||
Other Non-Cash Items | ||||
Changes in Working Capital | 0.029 | 0.74 | -0.022 | -0.41 |
Change in Accounts Receivable | ||||
Change in Inventories | ||||
Change in Accounts Payable | ||||
Change in Taxes Payable | ||||
Other Operating Cash Flow | ||||
Cash from Operating Activities | 0.509 | 0.467 | 0.116 | 0.036 |
Capital Expenditures | -0.025 | -0.019 | -0.028 | -0.008 |
Purchase of Fixed Assets | ||||
Other Investing Cash Flow Items | 0 | 0 | -0.045 | 0.287 |
Sale of Fixed Assets | ||||
Change in Net Intangibles | ||||
Other Investing Cash Flow | ||||
Cash from Investing Activities | -0.025 | -0.019 | -0.073 | 0.279 |
Financing Cash Flow Items | -0.139 | -0.251 | -0.274 | -0.031 |
Other Financing Cash Flow | ||||
Total Cash Dividends Paid | ||||
Net Issuance / Retirement of Debt | ||||
Cash from Financing Activities | -0.484 | -0.288 | -0.669 | -0.337 |
Beginning Cash Balance | ||||
Ending Cash Balance | ||||
Net Change in Cash | 0 | 0.159 | -0.626 | -0.022 |